Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II of Oral Satraplatin in Patients With Metastatic Breast Cancer (MBC)

NCT00265655 is registered in ClinicalTrials.gov with Agennix as lead sponsor.

NCT NCT00265655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II of Oral Satraplatin in Patients With Metastatic Breast Cancer (MBC)
Lead sponsor
Agennix
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
February 29, 2008
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer